Jasper Therapeutics annual free cash flow
2021
2022
2023
2024
2025
Jasper Therapeutics reported −$77.2M in free cash flow for fiscal 2025, a decrease of $14.0M from the previous fiscal year.
View full Jasper Therapeutics company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$77.2M | −$14.0M | — | — |
| 2024 | 2024-12-31 | −$63.2M | −$10.8M | — | — |
| 2023 | 2023-12-31 | −$52.3M | −$5.9M | — | — |
| 2022 | 2022-12-31 | −$46.4M | −$10.3M | — | — |
| 2021 | 2021-12-31 | −$36.1M | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | −$17.0M | −$1.2M | — | — |
| Q4 2024 | 2024-12-31 | −$21.2M | −$4.5M | — | — |
| Q3 2024 | 2024-09-30 | −$14.3M | −$2.3M | — | — |
| Q2 2024 | 2024-06-30 | −$11.8M | $1.4M | — | — |
| Q1 2024 | 2024-03-31 | −$15.8M | −$5.4M | — | — |
| Q4 2023 | 2023-12-31 | −$16.7M | −$4.0M | — | — |
| Q3 2023 | 2023-09-30 | −$12.0M | −$2.1M | — | — |
| Q2 2023 | 2023-06-30 | −$13.3M | −$3.7M | — | — |
| Q1 2023 | 2023-03-31 | −$10.4M | $3.9M | — | — |
| Q4 2022 | 2022-12-31 | −$12.7M | $2.6M | — | — |
| Q3 2022 | 2022-09-30 | −$9.9M | −$2.3M | — | — |
| Q2 2022 | 2022-06-30 | −$9.6M | −$3.5M | — | — |
| Q1 2022 | 2022-03-31 | −$14.2M | −$7.1M | — | — |
| Q4 2021 | 2021-12-31 | −$15.3M | — | — | — |
| Q3 2021 | 2021-09-30 | −$7.6M | — | — | — |
| Q2 2021 | 2021-06-30 | −$6.1M | — | — | — |
| Q1 2021 | 2021-03-31 | −$7.2M | — | — | — |
Jasper Therapeutics's latest reported quarter, Q3 2025, generated −$17.0M in free cash flow, a decrease of $1.2M year over year.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Jasper Therapeutics filings at SEC.gov ↗